Journal article
Addressing controversial areas in the management of advanced prostate cancer in Canada : Areas of consensus and controversy from the third Canadian consensus forum
Abstract
INTRODUCTION: The management of prostate cancer (PCa) is rapidly evolving. Treatment and diagnostic options grow annually, however, high-level evidence for the use of new therapeutics and diagnostics is lacking. In November 2022, the Genitourinary Research Consortium held its 3rd Canadian Consensus Forum (CCF3) to provide guidance on key controversial areas for management of PCa.
METHODS: A steering committee of eight multidisciplinary …
Authors
Saad F; Hotte SJ; Noonan K; Malone S; Morash C; Niazi T; Rendon RA; Shayegan B; Basappa NS; Cagiannos I
Journal
Canadian Urological Association Journal, Vol. 18, No. 4, pp. e127–e137
Publisher
Canadian Urological Association Journal
Publication Date
April 2024
DOI
10.5489/cuaj.8537
ISSN
1911-6470